Global Statistics

All countries
548,935,393
Confirmed
Updated on June 26, 2022 8:18 pm
All countries
520,730,887
Recovered
Updated on June 26, 2022 8:18 pm
All countries
6,350,765
Deaths
Updated on June 26, 2022 8:18 pm
Thursday, October 6, 2022

Global Statistics

All countries
548,935,393
Confirmed
Updated on June 26, 2022 8:18 pm
All countries
520,730,887
Recovered
Updated on June 26, 2022 8:18 pm
All countries
6,350,765
Deaths
Updated on June 26, 2022 8:18 pm
Molderizer and Safe Shield

Panadol Cough & Cold, Decolgen in short supply as more Covid-19 patients self-medicate

Fauci Greenlit Paper From Wuhan-Affiliated Group While Downplaying Lab Leak Theory

Dr. Anthony Fauci edited a research paper from the organization that conducted research on infected bats with the Wuhan Institute of Virology while...

CDC ends daily reporting of cases and deaths

CDC ends daily reporting of cases and deaths ...

COVID v. Flu Risk, Winter Wave Potential – NBC Chicago

How concerned are experts about a winter surge in either COVID or flu or both? With temperatures cooling, some are expressing concerns. Here's...


SINGAPORE – Some over-the-counter medicine to treat fever, cough and cold are in short supply at pharmacies here, as more Covid-19 patients opt to self-medicate.

While more easily transmitted, the current dominant Omicron variant is less severe than the Delta one, with those infected suffering fever, sore throat and cough.

Checks by The Straits Times found that several pharmacies, including Watsons and Guardian, are running low on Panadol Cough & Cold and Decolgen – which are used to relieve symptoms brought about by a cold or flu.

Over on e-commerce platforms Lazada and Shopee, some sellers still have the two products in stock but in limited quantities.

On Guardian’s website, both products are sold out, which a spokesman attributed to more people self-medicating. The spokesman said the company is monitoring the situation and working with suppliers.

The supply of both Decolgen and Panadol is expected to “recover and stabilise” by end-August, while Guardian’s own brand of fever medication is still in stock across its 115 outlets.

A spokesman for Watsons, which has 99 branches, said new stock is expected between the middle of and end August, noting that its suppliers are facing shipment issues.

In response to queries by ST, Panadol manufacturer Haleon, which is based in Britain and has its Asia-Pacific headquarters here, said it is producing record quantities of the drug.

But it noted that demand for consumer health products to manage symptoms of cold and flu has been unprecedented and unpredictable lately.

“Combined with challenges faced across all global supply chains, there may be times when consumers struggle to find the variant of Panadol they prefer,” it added.

Earlier this year, customers in Singapore faced issues trying to find specific variants of Panadol as some stores ran out of stock.

These variants include Panadol Extra and Panadol Cough & Cold.

A FairPrice spokesman said the overall demand for medication that treats cough and fever has been elevated since the beginning of the year, which was when Omicron cases started to spike.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular

Fauci Greenlit Paper From Wuhan-Affiliated Group While Downplaying Lab Leak Theory

Dr. Anthony Fauci edited a research paper from the organization that conducted research on infected bats with the Wuhan Institute of Virology while...

Related Articles

Fauci Greenlit Paper From Wuhan-Affiliated Group While Downplaying Lab Leak Theory

Dr. Anthony Fauci edited a research paper from the organization that conducted research on infected bats with the Wuhan Institute of Virology while...